{"id":"c9efef6d-c38f-4786-b69e-6cd492683204","arxiv_id":"2501.18415","paper_version":1,"verdict":"CONDITIONAL","confidence":"HIGH","novelty_score":5.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":0,"one_line_summary":"A consensus framework for credibility assessment of ML predictors in in silico medicine, extending verification and validation from biophysical models.","lead":"This position paper from the In Silico World community proposes twelve statements and a seven-step process for assessing how much to trust machine learning predictors in medical decisions. It argues that ML predictors need a credibility assessment beyond simple reliability, similar to the requirements for biophysical simulations.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The seven-step process hinges on S2's requirement that true values come from a measurement chain at least one order of magnitude more accurate than the context-of-use error threshold; for many target QIs no such chain exists, leaving the central claim inapplicable where it is most needed.","rationale":"The reader's weakest_assumption identifies S2, and I agree that this is the single most load-bearing concern. The central claim is that credibility can be estimated via the same seven-step process for biophysical and ML predictors. Step S2 is not a minor implementation detail but a logical precondition: without true values that are themselves measured with an accuracy one order of magnitude better than the allowed error, the prediction error cannot be quantified, decomposed, or checked for expected distributions. The paper's own framing makes this acute: ML predictors are motivated by QIs that are difficult or impossible to measure directly, yet S2 demands a measurement chain for exactly those QIs. The paper does not provide a fallback for QIs where the only available labels are imperfect clinical assessments or where the reference standard is the predictor itself. This is a correctness risk rather than a disagreement with external consensus: the internal preconditions of the framework are incompatible with a substantial part of its intended application domain. The framework could be salvaged by explicitly restricting the claim to QIs satisfying S2, or by replacing the strict one-order-of-magnitude requirement with a formal treatment of reference-standard uncertainty. Because the paper is a position paper and the reader already assigned CONDITIONAL, my analysis does not change the verdict; it reinforces the need for the authors to address or relax S2. I give credit for the paper's clear identification of the silent-variable problem and the safety-layer/TPLC strategies; those contributions stand independently of the S2 issue.","tokens_in":8159,"tokens_out":6764,"duration_ms":67088,"concrete_test":"Take the paper's own motivating example (ML prediction of cardiac electrical activity from non-invasive ECGs) and compile the available reference measurements (invasive catheter mapping, epicardial mapping, explanted-heart optical mapping). For each, state the measurement uncertainty in QI units and compare with a clinically justified maximum error epsilon (e.g., activation-time threshold for arrhythmia diagnosis). If no reference chain achieves uncertainty <= epsilon/10, S2 is violated for the paper's flagship example. To generalize, repeat for 10 clinically deployed ML predictors with diverse QIs; if a majority fail the epsilon/10 test, the 'same general process' is not a general standard.","verdict_should_be":"UNCHANGED","load_bearing_attack":"Statement #010 S2 is a hard precondition: true values must come from a measurement chain whose accuracy is at least one order of magnitude smaller than the context-of-use error threshold. This condition is not satisfied for many QIs that the paper explicitly motivates. Statement #001 defines the QI as a quantity that can be quantified 'only under particular conditions'; the Discussion's cardiac example relies on invasive measurements. For QIs such as patient-reported pain, individual-level disease risk, or long-term outcomes, there is no independent measurement chain with the required accuracy: the only available labels are the predictor itself, fallible clinical assessments, or delayed outcomes with their own errors. In those cases steps S3–S6 cannot be executed, so the 'same general process' cannot yield a credibility estimate. The paper does not scope the process to QIs with a qualifying measurement chain, nor does it propose alternative anchors such as reference-standard uncertainty propagation or predictive-interval validation. Since these are precisely the cases where ML predictors are most needed, the central claim overreaches its precondition.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"This position paper from the In Silico World Community of Practice proposes a consensus framework for assessing the credibility of machine learning (ML) predictors in in silico medicine. It introduces twelve statements defining quantities of interest (QIs), implicit versus explicit causal knowledge, and a seven-step credibility assessment process (S1–S7) intended to apply to both biophysical and ML predictors. The central claim is that credibility can be estimated by the same general process for both predictor classes (Statement #010), with ML predictors differing mainly in that their input sets are sufficient but not necessarily necessary, so robustness to bias cannot be reduced to applicability alone (Statement #011). The paper advocates two mitigation strategies: a total product life cycle approach and a safety layer that checks new inputs against training/test distributions.","tokens_in":8218,"tokens_out":3606,"duration_ms":33555,"significance":"If the proposed framework is accepted as a basis for regulatory thinking, it would extend established credibility concepts (ASME V&V40, FDA guidance) to ML predictors and provide a structured vocabulary for discussing error sources, robustness, and applicability. The paper's strengths include its explicit step-by-step process, its concrete engagement with current FDA draft guidance, and its identification of a real gap: the distinction between applicability and robustness for ML predictors whose input sets are not known to be necessary. The strategies of TPLC and safety layers are actionable and testable in principle. However, the paper is a position statement rather than a validated methodology, and its central claim relies on premises that are asserted rather than demonstrated, particularly the availability of high-accuracy ground truth and the adequacy of the proposed error taxonomy.","major_comments":[{"comment":"The hard precondition that true values must come from a measurement chain with accuracy at least one order of magnitude smaller than the context-of-use error threshold is not satisfied for many QIs that the paper explicitly motivates (Statement #001, Introduction, Discussion). For patient-reported pain, individual-level disease risk, or long-term outcomes, no independent measurement chain with the required accuracy exists; the available labels are fallible clinical assessments or delayed outcomes with their own errors. In such cases steps S3–S6 cannot be executed, so the 'same general process' cannot yield a credibility estimate. The paper should either scope the framework to QIs with qualifying measurement chains or propose alternative anchors (e.g., reference-standard uncertainty propagation, validation against clinically relevant endpoints). This is load-bearing because it determines whether the central claim applies to the motivating cases.","section":"Statement #010, step S2"},{"comment":"The assertion that the aleatoric component of the prediction error 'should be distributed normally' is used as a check in step S6, but no justification is provided. For ML predictors, errors are often heteroscedastic, heavy-tailed, or multimodal, and the decomposition into aleatoric, numerical, and epistemic components is not unique. If the expected distribution is not derived from a measurement model or error-generation mechanism, step S6 becomes unfalsifiable in practice. The authors should either justify the normality assumption for the specific predictor classes they consider or replace it with distributional expectations derived from the identified error sources.","section":"Statement #006 and step S6"},{"comment":"The claim that both biophysical and ML predictors are affected by 'similar sources of error' (numerical, aleatoric, epistemic) is asserted rather than demonstrated. For ML predictors, the relevant error sources include label noise, sampling and optimization stochasticity, distribution shift, and model misspecification; mapping these onto the three V&V categories is not automatic. Because steps S4–S5 depend on this taxonomy, the paper should provide a worked example (e.g., the cardiac ECG example from the Discussion) showing how the decomposition is performed in practice, or it should revise the taxonomy to reflect ML-specific error sources. Without this, the 'same general process' claim remains an analogy rather than a demonstrated equivalence.","section":"Statement #011, step S1 (Identification of sources of error)"}],"minor_comments":[{"comment":"The statement numbering skips #005 and #009; the authors should renumber or explicitly state that these are intentionally absent.","section":"Statements list"},{"comment":"The manuscript inconsistently uses 'QI' and 'QoI' (e.g., Statement #003 uses 'QoI' in S3 and S6, elsewhere 'QI'); the notation should be unified.","section":"Throughout"},{"comment":"There is a duplicated phrase: 'for a detailed review, see (see, for example, [18][19])'; this should be corrected.","section":"Discussion, 'Position the consensus statement'"},{"comment":"The expression '𝜀!<𝜀' is unclear; it should be typeset as ε < ε_max with a definition of ε_max, since the maximum error threshold is central to the process.","section":"Statement #010, step S1"},{"comment":"The manuscript states that all 35 experts supported the consensus statement, but it does not describe how the consensus was reached (e.g., voting, Delphi rounds, or discussion); a brief methodological note would support the 'consensus' claim.","section":"Consensus process"}],"recommendation":"major_revision","confidential_remarks":"This is a position paper rather than a technical advance, so the journal's policy on consensus/position papers should be considered. The technical concerns in S2 are fixable by scoping the framework to QIs with qualifying measurement chains or by adding alternative validation anchors; the error-source taxonomy also needs a worked example. If the authors address these points, the paper could be a useful contribution to regulatory science for ML medical devices."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Short version: this is a consensus position paper, not a new empirical result, and it is upfront about that. Its value is in assembling the ASME V&V40 / FDA credibility logic into twelve statements and a seven-step process for ML predictors. The strongest part is the 'silent variable' discussion (Statement #011): because an ML predictor's input set is sufficient but not necessarily necessary, robustness assessment can't be reduced to applicability alone. That is a genuinely useful observation and the paper's real contribution.\n\nIt also does several things well. It places itself honestly in the literature, explicitly saying its concepts resonate with existing guidelines and that the contribution is the systematic assembly. The TPLC and safety-layer strategies are concrete and practical. The prose is clear, the structure is logical, and the authors distinguish credibility from reliability, interpretability, and explainability in a way that is useful for regulatory conversations.\n\nThe soft spots, in proportion. The biggest is S2 in Statement #010: the postulate that true values must come from a measurement chain at least one order of magnitude more accurate than the context-of-use error threshold. That is a hard precondition, and for many of the motivating QIs—patient-reported pain, long-term outcomes, individual disease risk—no such chain exists. The paper neither scopes the process to QIs that satisfy S2 nor offers alternative anchors. The stress-test note is right: the 'same general process' cannot be executed where S2 fails, and those are exactly the cases where ML predictors are most needed. This is a load-bearing limitation, not a nitpick. The aleatoric-normality assumption in Statement #006 is asserted rather than justified, though it is standard practice. The consensus process is thin (35 of 747 experts), but the paper does not hide it; I read that as a transparency plus, not a fatal flaw. The causal-knowledge premise (Statement #004) is definitional—knowledge is defined as a causation hypothesis—so it is internally coherent, even if one could argue that some predictions don't need causal grounding.\n\nBottom line: the framework is plausible and the paper is worth engaging. It is not a research result; it is a synthesis that could genuinely shape regulatory practice if the S2 issue gets addressed or explicitly scoped. I would send it to peer review rather than desk reject, with referees asked to press on S2 and on what happens when no qualifying measurement chain exists. Reading group: maybe. I'd cite it if I were writing about ML validation frameworks.","headline":"A useful, honest synthesis of credibility assessment for ML predictors in medicine, with a load-bearing ground-truth precision requirement that will need scoping or revision.","tokens_in":8834,"tokens_out":2770,"would_cite":true,"duration_ms":25380,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"The paper claims that the credibility of ML predictors in medicine can be estimated with the same seven-step process used for biophysical predictors, with robustness to bias as the key divergence.","keywords":["machine learning","credibility assessment","in silico medicine","uncertainty quantification","robustness to bias","context of use","quantity of interest","biophysical predictors"],"falsifier":"Find any clinically deployed ML predictor whose credible assessment was performed without a measurement chain ten times more accurate than the error threshold, or run a controlled experiment in which a variable that was silent in training is deliberately varied; if the predictor's error remains within the threshold in the latter case, the central robustness concern identified in Statement #011 would be refuted.","tokens_in":7869,"feed_emoji":"🩺","tokens_out":5729,"duration_ms":46547,"temperature":0.7,"pith_summary":"The paper argues that the credibility of a machine-learning medical predictor—its guaranteed accuracy across all allowed inputs—can be assessed with the same seven-step process already used for biophysical models. The process runs from defining the clinical context and error threshold, through measuring true values, quantifying and decomposing prediction error, to checking error distributions and robustness to bias. The authors claim the two model classes differ in one decisive respect: a biophysical model's input set is assumed necessary and sufficient, while an ML predictor's inputs are sufficient but not necessarily necessary. That is why ML robustness cannot be reduced to applicability alone and needs extra strategies such as lifecycle monitoring and a safety layer. The payoff, if correct, is a unified regulatory standard for evaluating ML predictors in high-stakes healthcare.","feed_headline":"Same credibility check works for ML and biophysical predictors","feed_subtitle":"The paper says ML inputs are sufficient but not necessary, so bias screening must go beyond applicability.","key_machinery":"The carrying mechanism is the seven-step credibility process (S1–S7), from context-of-use error thresholds through error decomposition to robustness-to-bias analysis, together with the sufficient-but-not-necessary distinction between ML and biophysical input sets. The distinction does the load-bearing work: it explains why ML predictors can hide a necessary observable quantity that never varied in the training set, and why robustness therefore needs dedicated strategies—total product lifecycle monitoring or an input-safety layer—rather than an assumption of smooth applicability.","core_discovery":"On the paper's own terms, the central discovery is that credibility can be estimated using the same general process for both biophysical and ML predictors (Statement #010): define the context of use and maximum acceptable error; obtain true values through measurement chains at least an order of magnitude more accurate than that error; quantify and decompose prediction error; check that each component behaves as expected; and finally assess robustness to biases and applicability. Statement #011 then identifies the one structural difference: the input set of a biophysical predictor is necessary and sufficient, whereas an ML predictor's input set is sufficient but not necessarily necessary. That difference makes ML robustness assessment irreducible to applicability and directs attention to variables that were silent in training, which is the most critical risk the paper identifies.","pith_inferences":["Editorial inference: the sufficient-but-not-necessary claim predicts a specific failure mode that can be tested experimentally—train an ML predictor on a cohort where a known causal variable is silent, then vary that variable in a holdout set and measure whether error stays within threshold.","Editorial inference: the order-of-magnitude measurement requirement implies that QIs without a high-accuracy reference measurement, such as pain or long-term outcomes, cannot be credentialed under this framework unless surrogate ground truths, like validated biophysical simulators, are accepted as measurement chains.","Editorial inference: the safety-layer proposal generalizes beyond medicine—any high-stakes ML deployment could adopt context-specific error thresholds plus distribution-shift checks instead of reporting a single accuracy number."],"forward_implications":["A single seven-step scaffold can guide credibility assessment for both ML and biophysical predictors, which would let regulators reuse familiar procedures when reviewing ML submissions.","For ML predictors, passing accuracy tests is not enough; developers must additionally show robustness to bias, either by expanding the certified context as diverse test sets accumulate or by adding a safety layer that detects out-of-population inputs.","The safety-layer strategy requires collecting and storing every observable quantity in training and test cohorts, even variables the predictor itself does not use, so that future inputs can be checked against the original population.","The framework treats error decomposition for ML predictors as achievable in principle, so developing an ML analogue of verification, validation, and uncertainty quantification becomes a concrete research target.","A credibility claim is always conditional on the defined context of use and limits of validity; changing the clinical use changes the error threshold and invalidates the previous assessment."],"supporting_citations":[{"why":"Supplies the established credibility-assessment procedure from computational-model regulation that the paper extends to ML predictors.","marker":"[18]"},{"why":"Defines best practice for computational modelling in regulatory use, the biophysical baseline the seven-step process is meant to generalize.","marker":"[19]"},{"why":"Provides the DIKW hierarchy the paper uses to distinguish raw data, information, causal knowledge, and validated wisdom.","marker":"[11]"},{"why":"Contrasts reliability with credibility, clarifying why a stricter guarantee than average accuracy is needed.","marker":"[12]"},{"why":"Documents underspecification failures in modern ML, supporting the paper's claim that robustness cannot be reduced to applicability.","marker":"[9]"},{"why":"Provides grounds for hybrid physics-informed ML as a route to strengthen credibility when explicit knowledge is partial.","marker":"[15]"},{"why":"Supplies pointwise reliability evaluation methods that the paper positions against its credibility approach.","marker":"[13]"},{"why":"Makes the case for holistic reliability assessment of ML systems, a motivation for the consensus framework.","marker":"[10]"}],"fun_headline_variants":["Credibility check unifies ML and biophysical predictors","ML predictors need bias checks beyond applicability","Same credibility framework, but ML inputs aren't necessary","For ML, sufficient inputs don't mean necessary inputs","Key ML credibility risk: silent variables in training"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The framework assumes that true values for the quantity of interest and its correlated quantities can always be obtained through a measurement chain at least ten times more accurate than the acceptable error; for many clinically important quantities, no such ground-truth measurement exists.","fun_headline_variants_meta":{"raw":{"variants":["Credibility check unifies ML and biophysical predictors","ML predictors need bias checks beyond applicability","Same credibility framework, but ML inputs aren't necessary","For ML, sufficient inputs don't mean necessary inputs","Key ML credibility risk: silent variables in training"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000203,"raw_usage":{"total_tokens":1319,"prompt_tokens":815,"completion_tokens":504,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":431,"completion_tokens_details":{"reasoning_tokens":432}},"tokens_in":431,"tokens_out":504,"duration_ms":4181,"temperature":1.0,"reasoning_tokens":432,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-09T23:33:36.510141+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Find any clinically deployed ML predictor whose credible assessment was performed without a measurement chain ten times more accurate than the error threshold, or run a controlled experiment in which a variable that was silent in training is deliberately varied; if the predictor's error remains within the threshold in the latter case, the central robustness concern identified in Statement #011 would be refuted.","supporting_citations":[{"cited_title":"The wisdom hierarchy: representations of the DIKW hierarchy","cited_arxiv_id":null,"evidence_quote":"Provides the DIKW hierarchy the paper uses to distinguish raw data, information, causal knowledge, and validated wisdom."}],"review_version":1}